Curaleaf International Launches a Range of Medical Cannabis Products in Australia
Curaleaf Holdings (CURLF) has announced its entry into the Australian medical cannabis market through the launch of Curaleaf branded products. The initial offering includes four cannabis flower strains that will be distributed through Canngea, a licensed Australian manufacturer and wholesaler.
The company plans to expand its portfolio in the coming months with precision-dosed inhalation formats and popular strains currently prescribed in the UK, Germany, and other European markets. The Australian market is projected to exceed $1 billion in annual sales next year, representing a significant opportunity for Curaleaf's global expansion strategy.
Curaleaf Holdings (CURLF) ha annunciato il suo ingresso nel mercato australiano della cannabis medica con il lancio dei prodotti a marchio Curaleaf. L'offerta iniziale comprende quattro varietà di fiori di cannabis che saranno distribuite tramite Canngea, un produttore e grossista australiano autorizzato.
L'azienda prevede di ampliare il proprio portafoglio nei prossimi mesi con formati di inalazione a dosaggio preciso e varietà popolari attualmente prescritte nel Regno Unito, in Germania e in altri mercati europei. Si prevede che il mercato australiano supererà il miliardo di dollari in vendite annuali il prossimo anno, rappresentando un'opportunità significativa per la strategia di espansione globale di Curaleaf.
Curaleaf Holdings (CURLF) ha anunciado su entrada en el mercado australiano de cannabis medicinal con el lanzamiento de productos bajo la marca Curaleaf. La oferta inicial incluye cuatro variedades de flores de cannabis que se distribuirán a través de Canngea, un fabricante y mayorista australiano con licencia.
La compañía planea ampliar su portafolio en los próximos meses con formatos de inhalación de dosis precisas y variedades populares actualmente prescritas en el Reino Unido, Alemania y otros mercados europeos. Se proyecta que el mercado australiano superará los mil millones de dólares en ventas anuales el próximo año, lo que representa una oportunidad significativa para la estrategia de expansión global de Curaleaf.
Curaleaf Holdings (CURLF)가 Curaleaf 브랜드 제품 출시를 통해 호주 의료용 대마초 시장에 진출했다고 발표했습니다. 초기 제품으로는 네 가지 대마초 꽃 품종이 포함되며, 이는 호주에서 허가받은 제조업체이자 도매업체인 Canngea를 통해 유통될 예정입니다.
회사는 향후 몇 달 내에 영국, 독일 및 기타 유럽 시장에서 현재 처방되고 있는 인기 품종과 정밀 용량 흡입 형식을 포함해 포트폴리오를 확장할 계획입니다. 호주 시장은 내년에 연간 매출 10억 달러를 초과할 것으로 예상되며, 이는 Curaleaf의 글로벌 확장 전략에 중요한 기회를 의미합니다.
Curaleaf Holdings (CURLF) a annoncé son entrée sur le marché australien du cannabis médical avec le lancement de produits sous la marque Curaleaf. L'offre initiale comprend quatre variétés de fleurs de cannabis qui seront distribuées via Canngea, un fabricant et grossiste australien agréé.
L'entreprise prévoit d'élargir son portefeuille dans les mois à venir avec des formats d'inhalation à dosage précis et des variétés populaires actuellement prescrites au Royaume-Uni, en Allemagne et dans d'autres marchés européens. Le marché australien devrait dépasser le milliard de dollars de ventes annuelles l'année prochaine, représentant une opportunité majeure pour la stratégie d'expansion mondiale de Curaleaf.
Curaleaf Holdings (CURLF) hat seinen Eintritt in den australischen medizinischen Cannabismarkt durch die Einführung von Curaleaf-Markenprodukten bekannt gegeben. Das Anfangsangebot umfasst vier Cannabisblütensorten, die über Canngea, einen lizenzierten australischen Hersteller und Großhändler, vertrieben werden.
Das Unternehmen plant, sein Portfolio in den kommenden Monaten mit präzise dosierten Inhalationsformaten und beliebten Sorten, die derzeit im Vereinigten Königreich, Deutschland und anderen europäischen Märkten verschrieben werden, zu erweitern. Für den australischen Markt wird prognostiziert, dass die jährlichen Umsätze im nächsten Jahr eine Milliarde US-Dollar übersteigen werden, was eine bedeutende Chance für Curaleafs globale Expansionsstrategie darstellt.
- Entry into Australia's rapidly growing medical cannabis market, expected to reach $1B+ in annual sales next year
- Partnership with established local distributor Canngea for market access
- Planned expansion of product portfolio with proven formulations from European markets
- None.
The initial product offering, comprising four cannabis flower strains, will be distributed via Canngea, a licensed Australian manufacturer and wholesaler with a wealth of experience in medical cannabis. This partnership supports Curaleaf's vision to be the world's leading cannabis company by consistently delivering superior products and services.
Over the coming months, patients and healthcare professionals in
Juan Martinez, Head of Curaleaf International, commented: "Entering the Australian market is a significant milestone in our global strategy to expand access to high-quality, evidence-backed cannabis medicines. We're committed to supporting Australian patients and healthcare professionals with reliable, consistent products and the backing of one of the industry's most advanced supply chains."
Boris Jordan, Chairman and CEO of Curaleaf, added: "
About Curaleaf International
Curaleaf International is shaping the future of cannabis through its commitment to research and product excellence. Powered by a strong presence at all stages of the supply chain, its unique distribution network throughout
Curaleaf International's network includes a clinic, pharmacy, and laboratory in the
Curaleaf International is part of Curaleaf Holdings, Inc., a leading international producer and distributor of consumer cannabis products.
Media Contact:
Curaleaf International:
Beth Sweet-Escott
Head of Communications, Curaleaf International
media@curaleafint.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-international-launches-a-range-of-medical-cannabis-products-in-australia-302456534.html
SOURCE Curaleaf International
FAQ
What products is Curaleaf (CURLF) launching in Australia?
How big is the Australian medical cannabis market where Curaleaf (CURLF) is expanding?
Who is Curaleaf's distribution partner in Australia?
What are Curaleaf's (CURLF) expansion plans for the Australian market?
